Selected research
Industry Growth & Trends
Global Pemetrexed Disodium Lyophilized Powder Industry Growth and Trends Forecast to 2032
Market perspective
The global Pemetrexed Disodium Lyophilized Powder market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pemetrexed Disodium Lyophilized Powder is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pemetrexed Disodium Lyophilized Powder is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pemetrexed Disodium Lyophilized Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pemetrexed Disodium Lyophilized Powder include Yangtze River Pharmaceutical Group, Jiangsu Simcere Pharmaceutical, Suzhou Thery Pharmaceutical, Suzhou Erye Pharmaceutical, Sichuan Huiyu Pharmaceutical, Shanghai Chemo Wanbang Biopharma, Zhendong Group, Sandoz and Jiangsu Hansoh Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pemetrexed Disodium Lyophilized Powder market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pemetrexed Disodium Lyophilized Powder market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pemetrexed Disodium Lyophilized Powder market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pemetrexed Disodium Lyophilized Powder.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Pemetrexed Disodium Lyophilized Powder market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pemetrexed Disodium Lyophilized Powder Market by Company
Yangtze River Pharmaceutical Group
Jiangsu Simcere Pharmaceutical
Suzhou Thery Pharmaceutical
Suzhou Erye Pharmaceutical
Sichuan Huiyu Pharmaceutical
Shanghai Chemo Wanbang Biopharma
Zhendong Group
Sandoz
Jiangsu Hansoh Pharmaceutical
Nanjing Pharmaceutical Factory
Lianyungang Jaripharm Pharmaceutical
Lilly
Qilu Pharmaceutical
Jiangsu Aosaikang Pharmaceutical
Kelun Pharmaceutical
Hainan Jinrui Pharmaceutical
Fresenius Kabi
Dezhou Deyao Pharmaceutical
Beijing Xiehe Pharmaceutical
Baxter
Zydus Lifesciences
Waverley Pharma
Pfizer (Hospira)
Nang Kuang Pharmaceutical
Eugia Pharma
Dr. Reddy's Laboratories
Biocon
APOTEX
Amneal Pharmaceuticals
Accord Healthcare
Pemetrexed Disodium Lyophilized Powder Segment by Type
100mg/Pcs
500mg/Pcs
Pemetrexed Disodium Lyophilized Powder Segment by Application
Hospitals
Clinics
Others
Pemetrexed Disodium Lyophilized Powder Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium Lyophilized Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium Lyophilized Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium Lyophilized Powder.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pemetrexed Disodium Lyophilized Powder manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Pemetrexed Disodium Lyophilized Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 100mg/Pcs
- 500mg/Pcs
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Yangtze River Pharmaceutical Group
- Jiangsu Simcere Pharmaceutical
- Suzhou Thery Pharmaceutical
- Suzhou Erye Pharmaceutical
- Sichuan Huiyu Pharmaceutical
- Shanghai Chemo Wanbang Biopharma
- Zhendong Group
- Sandoz
- Jiangsu Hansoh Pharmaceutical
- Nanjing Pharmaceutical Factory
- Lianyungang Jaripharm Pharmaceutical
- Lilly
- Qilu Pharmaceutical
- Jiangsu Aosaikang Pharmaceutical
- Kelun Pharmaceutical
- Hainan Jinrui Pharmaceutical
- Fresenius Kabi
- Dezhou Deyao Pharmaceutical
- Beijing Xiehe Pharmaceutical
- Baxter
- Zydus Lifesciences
- Waverley Pharma
- Pfizer (Hospira)
- Nang Kuang Pharmaceutical
- Eugia Pharma
- Dr. Reddy's Laboratories
- Biocon
- APOTEX
- Amneal Pharmaceuticals
- Accord Healthcare
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Pemetrexed Disodium Lyophilized Powder Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales Estimates and Forecasts (2021-2032)
- 1.3 Pemetrexed Disodium Lyophilized Powder Market by Type
- 1.3.1 100mg/Pcs
- 1.3.2 500mg/Pcs
- 1.4 Global Pemetrexed Disodium Lyophilized Powder Market Size by Type
- 1.4.1 Global Pemetrexed Disodium Lyophilized Powder Market Size Overview by Type (2021-2032)
- 1.4.2 Global Pemetrexed Disodium Lyophilized Powder Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Pemetrexed Disodium Lyophilized Powder Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Pemetrexed Disodium Lyophilized Powder Industry Trends
- 2.2 Pemetrexed Disodium Lyophilized Powder Industry Drivers
- 2.3 Pemetrexed Disodium Lyophilized Powder Industry Opportunities and Challenges
- 2.4 Pemetrexed Disodium Lyophilized Powder Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Pemetrexed Disodium Lyophilized Powder Revenue (2021-2026)
- 3.2 Global Top Players by Pemetrexed Disodium Lyophilized Powder Sales (2021-2026)
- 3.3 Global Top Players by Pemetrexed Disodium Lyophilized Powder Price (2021-2026)
- 3.4 Global Pemetrexed Disodium Lyophilized Powder Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pemetrexed Disodium Lyophilized Powder Major Company Production Sites & Headquarters
- 3.6 Global Pemetrexed Disodium Lyophilized Powder Company, Product Type & Application
- 3.7 Global Pemetrexed Disodium Lyophilized Powder Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pemetrexed Disodium Lyophilized Powder Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pemetrexed Disodium Lyophilized Powder Players Market Share by Revenue in 2025
- 3.8.3 2025 Pemetrexed Disodium Lyophilized Powder Tier 1, Tier 2, and Tier 3
4 Pemetrexed Disodium Lyophilized Powder Regional Status and Outlook
- 4.1 Global Pemetrexed Disodium Lyophilized Powder Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Pemetrexed Disodium Lyophilized Powder Historic Market Size by Region
- 4.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales in Volume by Region (2021-2026)
- 4.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales in Value by Region (2021-2026)
- 4.2.3 Global Pemetrexed Disodium Lyophilized Powder Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Pemetrexed Disodium Lyophilized Powder Forecasted Market Size by Region
- 4.3.1 Global Pemetrexed Disodium Lyophilized Powder Sales in Volume by Region (2027-2032)
- 4.3.2 Global Pemetrexed Disodium Lyophilized Powder Sales in Value by Region (2027-2032)
- 4.3.3 Global Pemetrexed Disodium Lyophilized Powder Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pemetrexed Disodium Lyophilized Powder by Application
- 5.1 Pemetrexed Disodium Lyophilized Powder Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Pemetrexed Disodium Lyophilized Powder Market Size by Application
- 5.2.1 Global Pemetrexed Disodium Lyophilized Powder Market Size Overview by Application (2021-2032)
- 5.2.2 Global Pemetrexed Disodium Lyophilized Powder Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Pemetrexed Disodium Lyophilized Powder Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yangtze River Pharmaceutical Group
- 6.1.1 Yangtze River Pharmaceutical Group Company Information
- 6.1.2 Yangtze River Pharmaceutical Group Business Overview
- 6.1.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.1.5 Yangtze River Pharmaceutical Group Recent Developments
- 6.2 Jiangsu Simcere Pharmaceutical
- 6.2.1 Jiangsu Simcere Pharmaceutical Company Information
- 6.2.2 Jiangsu Simcere Pharmaceutical Business Overview
- 6.2.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.2.5 Jiangsu Simcere Pharmaceutical Recent Developments
- 6.3 Suzhou Thery Pharmaceutical
- 6.3.1 Suzhou Thery Pharmaceutical Company Information
- 6.3.2 Suzhou Thery Pharmaceutical Business Overview
- 6.3.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.3.5 Suzhou Thery Pharmaceutical Recent Developments
- 6.4 Suzhou Erye Pharmaceutical
- 6.4.1 Suzhou Erye Pharmaceutical Company Information
- 6.4.2 Suzhou Erye Pharmaceutical Business Overview
- 6.4.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.4.5 Suzhou Erye Pharmaceutical Recent Developments
- 6.5 Sichuan Huiyu Pharmaceutical
- 6.5.1 Sichuan Huiyu Pharmaceutical Company Information
- 6.5.2 Sichuan Huiyu Pharmaceutical Business Overview
- 6.5.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.5.5 Sichuan Huiyu Pharmaceutical Recent Developments
- 6.6 Shanghai Chemo Wanbang Biopharma
- 6.6.1 Shanghai Chemo Wanbang Biopharma Company Information
- 6.6.2 Shanghai Chemo Wanbang Biopharma Business Overview
- 6.6.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.6.5 Shanghai Chemo Wanbang Biopharma Recent Developments
- 6.7 Zhendong Group
- 6.7.1 Zhendong Group Company Information
- 6.7.2 Zhendong Group Business Overview
- 6.7.3 Zhendong Group Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Zhendong Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.7.5 Zhendong Group Recent Developments
- 6.8 Sandoz
- 6.8.1 Sandoz Company Information
- 6.8.2 Sandoz Business Overview
- 6.8.3 Sandoz Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Sandoz Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.8.5 Sandoz Recent Developments
- 6.9 Jiangsu Hansoh Pharmaceutical
- 6.9.1 Jiangsu Hansoh Pharmaceutical Company Information
- 6.9.2 Jiangsu Hansoh Pharmaceutical Business Overview
- 6.9.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.9.5 Jiangsu Hansoh Pharmaceutical Recent Developments
- 6.10 Nanjing Pharmaceutical Factory
- 6.10.1 Nanjing Pharmaceutical Factory Company Information
- 6.10.2 Nanjing Pharmaceutical Factory Business Overview
- 6.10.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.10.5 Nanjing Pharmaceutical Factory Recent Developments
- 6.11 Lianyungang Jaripharm Pharmaceutical
- 6.11.1 Lianyungang Jaripharm Pharmaceutical Company Information
- 6.11.2 Lianyungang Jaripharm Pharmaceutical Business Overview
- 6.11.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.11.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
- 6.12 Lilly
- 6.12.1 Lilly Company Information
- 6.12.2 Lilly Business Overview
- 6.12.3 Lilly Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Lilly Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.12.5 Lilly Recent Developments
- 6.13 Qilu Pharmaceutical
- 6.13.1 Qilu Pharmaceutical Company Information
- 6.13.2 Qilu Pharmaceutical Business Overview
- 6.13.3 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.13.5 Qilu Pharmaceutical Recent Developments
- 6.14 Jiangsu Aosaikang Pharmaceutical
- 6.14.1 Jiangsu Aosaikang Pharmaceutical Company Information
- 6.14.2 Jiangsu Aosaikang Pharmaceutical Business Overview
- 6.14.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
- 6.15 Kelun Pharmaceutical
- 6.15.1 Kelun Pharmaceutical Company Information
- 6.15.2 Kelun Pharmaceutical Business Overview
- 6.15.3 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.15.5 Kelun Pharmaceutical Recent Developments
- 6.16 Hainan Jinrui Pharmaceutical
- 6.16.1 Hainan Jinrui Pharmaceutical Company Information
- 6.16.2 Hainan Jinrui Pharmaceutical Business Overview
- 6.16.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.16.5 Hainan Jinrui Pharmaceutical Recent Developments
- 6.17 Fresenius Kabi
- 6.17.1 Fresenius Kabi Company Information
- 6.17.2 Fresenius Kabi Business Overview
- 6.17.3 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.17.5 Fresenius Kabi Recent Developments
- 6.18 Dezhou Deyao Pharmaceutical
- 6.18.1 Dezhou Deyao Pharmaceutical Company Information
- 6.18.2 Dezhou Deyao Pharmaceutical Business Overview
- 6.18.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.18.5 Dezhou Deyao Pharmaceutical Recent Developments
- 6.19 Beijing Xiehe Pharmaceutical
- 6.19.1 Beijing Xiehe Pharmaceutical Company Information
- 6.19.2 Beijing Xiehe Pharmaceutical Business Overview
- 6.19.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.19.5 Beijing Xiehe Pharmaceutical Recent Developments
- 6.20 Baxter
- 6.20.1 Baxter Company Information
- 6.20.2 Baxter Business Overview
- 6.20.3 Baxter Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 Baxter Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.20.5 Baxter Recent Developments
- 6.21 Zydus Lifesciences
- 6.21.1 Zydus Lifesciences Company Information
- 6.21.2 Zydus Lifesciences Business Overview
- 6.21.3 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.21.5 Zydus Lifesciences Recent Developments
- 6.22 Waverley Pharma
- 6.22.1 Waverley Pharma Company Information
- 6.22.2 Waverley Pharma Business Overview
- 6.22.3 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.22.4 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.22.5 Waverley Pharma Recent Developments
- 6.23 Pfizer (Hospira)
- 6.23.1 Pfizer (Hospira) Company Information
- 6.23.2 Pfizer (Hospira) Business Overview
- 6.23.3 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.23.4 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.23.5 Pfizer (Hospira) Recent Developments
- 6.24 Nang Kuang Pharmaceutical
- 6.24.1 Nang Kuang Pharmaceutical Company Information
- 6.24.2 Nang Kuang Pharmaceutical Business Overview
- 6.24.3 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.24.4 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.24.5 Nang Kuang Pharmaceutical Recent Developments
- 6.25 Eugia Pharma
- 6.25.1 Eugia Pharma Company Information
- 6.25.2 Eugia Pharma Business Overview
- 6.25.3 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.25.4 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.25.5 Eugia Pharma Recent Developments
- 6.26 Dr. Reddy's Laboratories
- 6.26.1 Dr. Reddy's Laboratories Company Information
- 6.26.2 Dr. Reddy's Laboratories Business Overview
- 6.26.3 Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.26.4 Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.26.5 Dr. Reddy's Laboratories Recent Developments
- 6.27 Biocon
- 6.27.1 Biocon Company Information
- 6.27.2 Biocon Business Overview
- 6.27.3 Biocon Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.27.4 Biocon Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.27.5 Biocon Recent Developments
- 6.28 APOTEX
- 6.28.1 APOTEX Company Information
- 6.28.2 APOTEX Business Overview
- 6.28.3 APOTEX Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.28.4 APOTEX Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.28.5 APOTEX Recent Developments
- 6.29 Amneal Pharmaceuticals
- 6.29.1 Amneal Pharmaceuticals Company Information
- 6.29.2 Amneal Pharmaceuticals Business Overview
- 6.29.3 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.29.4 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.29.5 Amneal Pharmaceuticals Recent Developments
- 6.30 Accord Healthcare
- 6.30.1 Accord Healthcare Company Information
- 6.30.2 Accord Healthcare Business Overview
- 6.30.3 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Sales, Revenue and Gross Margin (2021-2026)
- 6.30.4 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Product Portfolio
- 6.30.5 Accord Healthcare Recent Developments
7 North America by Country
- 7.1 North America Pemetrexed Disodium Lyophilized Powder Sales by Country
- 7.1.1 North America Pemetrexed Disodium Lyophilized Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026)
- 7.1.3 North America Pemetrexed Disodium Lyophilized Powder Sales Forecast by Country (2027-2032)
- 7.2 North America Pemetrexed Disodium Lyophilized Powder Market Size by Country
- 7.2.1 North America Pemetrexed Disodium Lyophilized Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Pemetrexed Disodium Lyophilized Powder Market Size by Country (2021-2026)
- 7.2.3 North America Pemetrexed Disodium Lyophilized Powder Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Pemetrexed Disodium Lyophilized Powder Sales by Country
- 8.1.1 Europe Pemetrexed Disodium Lyophilized Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026)
- 8.1.3 Europe Pemetrexed Disodium Lyophilized Powder Sales Forecast by Country (2027-2032)
- 8.2 Europe Pemetrexed Disodium Lyophilized Powder Market Size by Country
- 8.2.1 Europe Pemetrexed Disodium Lyophilized Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Pemetrexed Disodium Lyophilized Powder Market Size by Country (2021-2026)
- 8.2.3 Europe Pemetrexed Disodium Lyophilized Powder Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales by Country
- 9.1.1 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Market Size by Country
- 9.2.1 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Pemetrexed Disodium Lyophilized Powder Sales by Country
- 10.1.1 South America Pemetrexed Disodium Lyophilized Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026)
- 10.1.3 South America Pemetrexed Disodium Lyophilized Powder Sales Forecast by Country (2027-2032)
- 10.2 South America Pemetrexed Disodium Lyophilized Powder Market Size by Country
- 10.2.1 South America Pemetrexed Disodium Lyophilized Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Pemetrexed Disodium Lyophilized Powder Market Size by Country (2021-2026)
- 10.2.3 South America Pemetrexed Disodium Lyophilized Powder Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales by Country
- 11.1.1 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Size by Country
- 11.2.1 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Pemetrexed Disodium Lyophilized Powder Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Pemetrexed Disodium Lyophilized Powder Value Chain Analysis
- 12.1.1 Pemetrexed Disodium Lyophilized Powder Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Pemetrexed Disodium Lyophilized Powder Production Mode & Process
- 12.2 Pemetrexed Disodium Lyophilized Powder Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Pemetrexed Disodium Lyophilized Powder Distributors
- 12.2.3 Pemetrexed Disodium Lyophilized Powder Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst